FDA chief: Personalized medicine will spur industry collaborations

11/11/2008 | Philadelphia Inquirer, The

Major medical advances and scientific discoveries will bring together drugmakers, small biotech firms and medical-device manufacturers to develop more personalized treatments for patients with cancer and other life-threatening diseases, according to FDA chief Dr. Andrew von Eschenbach. These developments also could change the way companies test treatments and force the FDA to overhaul its drug-review process, von Eschenbach said.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health